Show simple item record

dc.contributor.authorSimões, D.
dc.contributor.authorRiva, P.
dc.contributor.authorPeliciari-Garcia, R.
dc.contributor.authorCruzat, Vinicius
dc.contributor.authorGraciano, M.
dc.contributor.authorMunhoz, A.
dc.contributor.authorTaneda, M.
dc.contributor.authorCipolla-Neto, J.
dc.contributor.authorCarpinelli, A.
dc.date.accessioned2017-01-30T11:41:34Z
dc.date.available2017-01-30T11:41:34Z
dc.date.created2016-12-28T19:30:21Z
dc.date.issued2016
dc.identifier.citationSimões, D. and Riva, P. and Peliciari-Garcia, R. and Cruzat, V. and Graciano, M. and Munhoz, A. and Taneda, M. et al. 2016. Melatonin modifies basal and stimulated insulin secretion via NADPH oxidase. Journal of Endocrinology. 231 (3): pp. 235-244.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/14118
dc.identifier.doi10.1530/JOE-16-0259
dc.description.abstract

Melatonin is a hormone synthesized in the pineal gland, which modulates several functions within the organism, including the synchronization of glucose metabolism and glucosestimulated insulin secretion (GSIS). Melatonin can mediate different signaling pathways in pancreatic islets through two membrane receptors and via antioxidant or pro-oxidant enzymes modulation. NADPH oxidase (NOX) is a pro-oxidant enzyme responsible for the production of the reactive oxygen specie (ROS) superoxide, generated from molecular oxygen. In pancreatic islets, NOX-derived ROS can modulate glucose metabolism and regulate insulin secretion. Considering the roles of both melatonin and NOX in islets, the aim of this study was to evaluate the association of NOX and ROS production on glucose metabolism, basal and GSIS in pinealectomized rats (PINX) and in melatonin-treated isolated pancreatic islets. Our results showed that ROS content derived from NOX activity was increased in PINX at baseline (2.8 mM glucose), which was followed by a reduction in glucose metabolism and basal insulin secretion in this group. Under 16.7 mM glucose, an increase in both glucose metabolism and GSIS was observed in PINX islets, without changes in ROS content. In isolated pancreatic islets from control animals incubated with 2.8 mM glucose, melatonin treatment reduced ROS content, whereas in 16.7 mM glucose, melatonin reduced ROS and GSIS. In conclusion, our results demonstrate that both basal and stimulated insulin secretion can be regulated by melatonin through the maintenance of ROS homeostasis in pancreatic islets.

dc.publisherBioScientifica
dc.titleMelatonin modifies basal and stimulated insulin secretion via NADPH oxidase
dc.typeJournal Article
dcterms.source.volume231
dcterms.source.number3
dcterms.source.startPage235
dcterms.source.endPage244
dcterms.source.issn0022-0795
dcterms.source.titleJournal of Endocrinology
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record